RNAC

Cartesian Therapeutics, Inc. - Common Stock (RNAC)

About Cartesian Therapeutics, Inc. - Common Stock (RNAC)

Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company was founded on December 10, 2007 is headquartered in Frederick, MD.

Details

Daily high
$8.26
Daily low
$7.66
Price at open
--
52 Week High
$11.00
52 Week Low
$5.60
Market cap
243.0M
Dividend yield
-
Volume
24
Avg. volume
108,147
P/E ratio
-1.35

Cartesian Therapeutics, Inc. - Common Stock News

Details

Daily high
$8.26
Daily low
$7.66
Price at open
--
52 Week High
$11.00
52 Week Low
$5.60
Market cap
243.0M
Dividend yield
-
Volume
24
Avg. volume
108,147
P/E ratio
-1.35